Highly relevant expression of DTYMK and MAPKAPK2 was also found in HCC (r = 0.229, p < 0.001), kidney chromophobe (KICH, r = 0.468, p < 0.001), thyroid carcinoma (THCA, r = 0.281, p < 0.001), pancreatic adenocarcinoma (r = 0.333, p < 0.001), brain lower-grade glioma (r = 0.476, p < 0.001), and uveal melanoma (r = 0.318, p = 0.004) (Fig. 3J). Here, DTYMK is linked to central nervous system cancer.